|
|
|
Insider
Information: |
Keane William P |
Relationship: |
Director |
City: |
Berkeley Heights |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
6,000 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
6,000 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Genta Inc De |
GNTAQ |
Chief Financial Officer |
2003-09-15 |
6,000 |
2003-09-15 |
0 |
Premium* |
|
Salix Pharmaceuticals Ltd |
SLXP |
Director |
2015-04-01 |
0 |
2006-07-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GNTAQ |
Genta Inc De |
Chief Financial Officer |
|
2003-09-15 |
4 |
B |
$14.00 |
$28,000 |
D/D |
2,000 |
6,000 |
2.74 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2006-02-28 |
4 |
A |
$15.95 |
$31,898 |
D/D |
2,000 |
2,000 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2006-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
12,000 |
|
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2007-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,230 |
21,230 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2007-07-03 |
4 |
AS |
$12.29 |
$42,640 |
D/D |
(3,467) |
17,763 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2008-05-09 |
4 |
B |
$6.62 |
$26,702 |
D/D |
4,000 |
21,763 |
2.39 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,676 |
31,268 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2008-07-01 |
4 |
D |
$7.03 |
$22,292 |
D/D |
(3,171) |
18,592 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2009-07-01 |
4 |
D |
$9.87 |
$42,984 |
D/D |
(4,355) |
26,913 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2009-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,160 |
39,073 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2010-07-01 |
4 |
D |
$39.03 |
$175,635 |
D/D |
(4,500) |
34,573 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2010-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,360 |
38,933 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,640 |
43,573 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2011-07-01 |
4 |
D |
$39.83 |
$64,286 |
D/D |
(1,614) |
41,959 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2011-12-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,200 |
40,759 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2012-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,160 |
43,202 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2013-04-15 |
4 |
AS |
$49.44 |
$1,483,200 |
D/D |
(30,000) |
33,202 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2013-04-15 |
4 |
OE |
$15.25 |
$457,398 |
D/D |
30,000 |
63,202 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2013-04-18 |
4 |
A |
$48.70 |
$200,157 |
D/D |
4,110 |
37,312 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2013-06-13 |
4 |
D |
$65.04 |
$121,755 |
D/D |
(1,872) |
35,440 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2013-12-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
200 |
35,240 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2014-01-07 |
4 |
AS |
$88.31 |
$1,986,975 |
D/D |
(22,500) |
35,240 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2014-01-07 |
4 |
OE |
$18.87 |
$424,649 |
D/D |
22,500 |
57,740 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2014-04-17 |
4 |
A |
$100.66 |
$320,602 |
D/D |
3,185 |
38,425 |
0 |
- |
|
SLXP |
Salix Pharmaceuticals Ltd |
Director |
|
2014-06-13 |
4 |
D |
$113.80 |
$210,530 |
D/D |
(1,850) |
36,575 |
0 |
- |
|
29 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|